Arrhythmias & electrophysiologyCohort study
Comprehensive assessment of novel cardiovascular biomarkers in atrial fibrillation (AF)
- Prospective cohort study
Authors' conclusion
All novel biomarkers Angpt2, BMP10, FGF23, and IGFBP7 showed predictive value for incident and recurrent AF. Individual biomarkers showed distinct strengths in prediction of outcomes across the disease spectrum of AF.
Study context
- Population
- Patients at risk of AF or with manifest arrhythmia527 prevalent AF, 507 AF-free
- Participants
- 1,047 patients
- Exposure
- Novel CV biomarkers vs NT-proBNP
- Outcome
- Combined endpoint: stroke, transient ischaemic attack (TIA), MI, incident CHD, HF and all-cause mortality
- Follow-up
- Median 42 months
Main finding
As reported in the abstract
Combined endpoint occurred
198
Deaths
66
Observational data: associations, not effects.
Original publication
Comprehensive assessment of novel cardiovascular biomarkers in AF. Europace. Published 15 May 2026. doi:10.1093/europace/euag096
Summarised from the published abstract; every number is checked against it